Nordea Investment Management Ab Amicus Therapeutics, Inc. Transaction History

Nordea Investment Management Ab

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$9.89 - $12.7 $42,487 - $54,559	-4,296 Reduced 0.66%	648,280 $7.92 Million
Q3 2022 Oct 19, 2022	SELL	$9.82 - $12.75 $423,497 - $549,856	-43,126 Reduced 6.2%	652,576 $6.91 Million
Q2 2022 Aug 09, 2022	SELL	$6.23 - $11.12 $533,350 - $951,983	-85,610 Reduced 10.96%	695,702 $7.38 Million
Q1 2022 Apr 11, 2022	BUY	$7.89 - $12.48 $363,918 - $575,627	46,124 Added 6.27%	781,312 $7.67 Million
Q4 2021 Jan 20, 2022	SELL	$9.82 - $12.44 $82,075 - $103,973	-8,358 Reduced 1.12%	735,188 $8.67 Million
Q3 2021 Nov 01, 2021	SELL	$8.74 - $11.84 $6.5 Million - $8.8 Million	-743,546 Reduced 50.0%	743,546 $7.35 Million
Q3 2021 Nov 01, 2021	BUY	$8.74 - $11.84 $6.43 Million - $8.71 Million	735,649 Added 97.9%	1,487,092 $14.2 Million
Q2 2021 Jul 16, 2021	BUY	$8.71 - $10.72 $6.55 Million - $8.06 Million	751,443 New	751,443 $7.24 Million

313

311M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.76B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

Stay updated on Nordea Investment Management Ab with notifications on news.